An approach to lifting self-isolation for health care workers with prolonged shedding of SARS-CoV-2 RNA.
Adult
COVID-19
/ diagnosis
COVID-19 Testing
/ methods
Cohort Studies
Convalescence
Decision Making
Enzyme-Linked Immunosorbent Assay
Female
Health Personnel
/ organization & administration
Humans
Male
Middle Aged
Nasopharynx
/ virology
Neutralization Tests
Oropharynx
/ virology
Quarantine
/ methods
Reverse Transcriptase Polymerase Chain Reaction
SARS-CoV-2
/ genetics
Time Factors
Virus Shedding
COVID-19
Health care worker
Infectiousness
Isolation
SARS-CV-2
Journal
Infection
ISSN: 1439-0973
Titre abrégé: Infection
Pays: Germany
ID NLM: 0365307
Informations de publication
Date de publication:
Feb 2021
Feb 2021
Historique:
received:
11
07
2020
accepted:
16
09
2020
pubmed:
8
10
2020
medline:
10
2
2021
entrez:
7
10
2020
Statut:
ppublish
Résumé
According to the European Public Health Authority guidance for ending isolation in the context of COVID-19, a convalescent healthcare worker (HCW) can end their isolation at home and resume work upon clinical improvement and two negative RT-PCR tests from respiratory specimens obtained at 24-h intervals at least 8 days after the onset of symptoms. However, convalescent HCWs may shed SARS-CoV-2 viral RNA for prolonged periods. 40 healthy HCWs off work because of ongoing positive RT-PCR results in combined nasopharyngeal (NP) and oropharyngeal (OP) swabs following SARS-CoV-2 infection were invited to participate in this study. These HCWs had been in self-isolation because of a PCR-confirmed SARS-CoV-2 infection. NP and OP swabs as well as a blood sample were collected from each participant. RT-PCR and virus isolation was performed with each swab sample and serum neutralization test as well as two different ELISA tests were performed on all serum samples. No viable virions could be detected in any of 29 nasopharyngeal and 29 oropharyngeal swabs taken from 15 long-time carriers. We found SARSCoV- 2 RNA in 14/29 nasopharyngeal and 10/29 oropharyngeal swabs obtained from screening 15 HCWs with previous COVID-19 up to 55 days after symptom onset. Six (40%) of the 15 initially positive HCWs converted to negative and later reverted to positive again according to their medical records. All but one HCW, a healthy volunteer banned from work, showed the presence of neutralizing antibodies in concomitantly taken blood samples. Late threshold cycle (Ct) values in RT-PCR [mean 37.4; median 37.3; range 30.8-41.7] and the lack of virus growth in cell culture indicate that despite the positive PCR results no infectivity remained. We recommend lifting isolation if the RT-PCR Ct-value of a naso- or oropharyngeal swab sample is over 30. Positive results obtained from genes targeted with Ct-values > 30 correspond to non-viable/noninfectious particles that are still detected by RT-PCR. In case of Ct-values lower than 30, a blood sample from the patient should be tested for the presence of neutralizing antibodies. If positive, non-infectiousness can also be assumed.
Identifiants
pubmed: 33025521
doi: 10.1007/s15010-020-01530-4
pii: 10.1007/s15010-020-01530-4
pmc: PMC7538033
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
95-101Références
Nature. 2020 Aug;584(7821):437-442
pubmed: 32555388
Nat Med. 2020 Aug;26(8):1200-1204
pubmed: 32555424
J Clin Microbiol. 2006 Sep;44(9):3366-7
pubmed: 16954274
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Eur J Clin Microbiol Infect Dis. 2020 Jun;39(6):1059-1061
pubmed: 32342252
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Clin Infect Dis. 2020 Dec 17;71(10):2663-2666
pubmed: 32442256
J Clin Microbiol. 2020 Jul 23;58(8):
pubmed: 32513858
Wien Klin Wochenschr. 2020 Nov;132(21-22):645-652
pubmed: 32816114
J Virol Methods. 2007 Mar;140(1-2):115-23
pubmed: 17196266
Emerg Infect Dis. 2021 Jan;27(1):
pubmed: 33261718
J Med Virol. 2010 Oct;82(10):1773-81
pubmed: 20827776
J Med Virol. 2020 Nov;92(11):2286-2287
pubmed: 32347980
Int J Infect Dis. 2020 Apr;93:284-286
pubmed: 32145466
N Engl J Med. 2020 Mar 19;382(12):1177-1179
pubmed: 32074444
J Virol. 2020 Aug 17;94(17):
pubmed: 32591466
JAMA Intern Med. 2020 Sep 1;180(9):1156-1163
pubmed: 32356867